Global Performance Enhancing Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

August 2018 | 123 pages | ID: GB7002A8D47GEN
GlobalInfoResearch

Abstracts

Performance-enhancing drugs (PED), are substances that are used to improve any form of activity performance in humans.

SCOPE OF THE REPORT:

This report focuses on the Performance Enhancing Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
A well-known example of PED involves doping in sport, where banned physical performance?enhancing drugs are used by athletes and bodybuilders. Athletic performance-enhancing substances are sometimes referred to as ergogenic aids. Cognitive performance-enhancing drugs, commonly called nootropics, are sometimes used by students to improve academic performance. Performance-enhancing substances are also used by military personnel to enhance combat performance.

The worldwide market for Performance Enhancing Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• Taj Pharmaceuticals
• Balkan Pharmaceuticals
• Bayer
• AstraZeneca
• Novo Nordisk
• BrainAlert
• Douglas Laboratories
• Onnit Labs
• Eli Lilly And Company

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Ergogenic Aids
• Nootropic

Market Segment by Applications, can be divided into

• Athletes
• Body Builders
• Students
• Militaries

There are 15 Chapters to deeply display the global Performance Enhancing Drugs market.

Chapter 1, to describe Performance Enhancing Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Performance Enhancing Drugs, with sales, revenue, and price of Performance Enhancing Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Performance Enhancing Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Performance Enhancing Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Performance Enhancing Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Performance Enhancing Drugs Introduction
1.2 Market Analysis by Type
  1.2.1 Ergogenic Aids
  1.2.2 Nootropic
1.3 Market Analysis by Applications
  1.3.1 Athletes
  1.3.2 Body Builders
  1.3.3 Students
  1.3.4 Militaries
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Taj Pharmaceuticals
  2.1.1 Business Overview
  2.1.2 Performance Enhancing Drugs Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Taj Pharmaceuticals Performance Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Balkan Pharmaceuticals
  2.2.1 Business Overview
  2.2.2 Performance Enhancing Drugs Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Balkan Pharmaceuticals Performance Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bayer
  2.3.1 Business Overview
  2.3.2 Performance Enhancing Drugs Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Bayer Performance Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 AstraZeneca
  2.4.1 Business Overview
  2.4.2 Performance Enhancing Drugs Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 AstraZeneca Performance Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novo Nordisk
  2.5.1 Business Overview
  2.5.2 Performance Enhancing Drugs Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Novo Nordisk Performance Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 BrainAlert
  2.6.1 Business Overview
  2.6.2 Performance Enhancing Drugs Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 BrainAlert Performance Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Douglas Laboratories
  2.7.1 Business Overview
  2.7.2 Performance Enhancing Drugs Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Douglas Laboratories Performance Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Onnit Labs
  2.8.1 Business Overview
  2.8.2 Performance Enhancing Drugs Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Onnit Labs Performance Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Eli Lilly And Company
  2.9.1 Business Overview
  2.9.2 Performance Enhancing Drugs Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Eli Lilly And Company Performance Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL PERFORMANCE ENHANCING DRUGS SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)

3.1 Global Performance Enhancing Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Performance Enhancing Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
  3.3.1 Top 3 Performance Enhancing Drugs Manufacturer Market Share in 2017
  3.3.2 Top 6 Performance Enhancing Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend

4 GLOBAL PERFORMANCE ENHANCING DRUGS MARKET ANALYSIS BY REGIONS

4.1 Global Performance Enhancing Drugs Sales, Revenue and Market Share by Regions
  4.1.1 Global Performance Enhancing Drugs Sales and Market Share by Regions (2013-2018)
  4.1.2 Global Performance Enhancing Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
4.5 South America Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Performance Enhancing Drugs Sales and Growth Rate (2013-2018)

5 NORTH AMERICA PERFORMANCE ENHANCING DRUGS BY COUNTRIES

5.1 North America Performance Enhancing Drugs Sales, Revenue and Market Share by Countries
  5.1.1 North America Performance Enhancing Drugs Sales and Market Share by Countries (2013-2018)
  5.1.2 North America Performance Enhancing Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Performance Enhancing Drugs Sales and Growth Rate (2013-2018)

6 EUROPE PERFORMANCE ENHANCING DRUGS BY COUNTRIES

6.1 Europe Performance Enhancing Drugs Sales, Revenue and Market Share by Countries
  6.1.1 Europe Performance Enhancing Drugs Sales and Market Share by Countries (2013-2018)
  6.1.2 Europe Performance Enhancing Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
6.3 UK Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
6.4 France Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Performance Enhancing Drugs Sales and Growth Rate (2013-2018)

7 ASIA-PACIFIC PERFORMANCE ENHANCING DRUGS BY COUNTRIES

7.1 Asia-Pacific Performance Enhancing Drugs Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Performance Enhancing Drugs Sales and Market Share by Countries (2013-2018)
  7.1.2 Asia-Pacific Performance Enhancing Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
7.5 India Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Performance Enhancing Drugs Sales and Growth Rate (2013-2018)

8 SOUTH AMERICA PERFORMANCE ENHANCING DRUGS BY COUNTRIES

8.1 South America Performance Enhancing Drugs Sales, Revenue and Market Share by Countries
  8.1.1 South America Performance Enhancing Drugs Sales and Market Share by Countries (2013-2018)
  8.1.2 South America Performance Enhancing Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Performance Enhancing Drugs Sales and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA PERFORMANCE ENHANCING DRUGS BY COUNTRIES

9.1 Middle East and Africa Performance Enhancing Drugs Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Performance Enhancing Drugs Sales and Market Share by Countries (2013-2018)
  9.1.2 Middle East and Africa Performance Enhancing Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Performance Enhancing Drugs Sales and Growth Rate (2013-2018)

10 GLOBAL PERFORMANCE ENHANCING DRUGS MARKET SEGMENT BY TYPE

10.1 Global Performance Enhancing Drugs Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Performance Enhancing Drugs Sales and Market Share by Type (2013-2018)
  10.1.2 Global Performance Enhancing Drugs Revenue and Market Share by Type (2013-2018)
10.2 Ergogenic Aids Sales Growth and Price
  10.2.1 Global Ergogenic Aids Sales Growth (2013-2018)
  10.2.2 Global Ergogenic Aids Price (2013-2018)
10.3 Nootropic Sales Growth and Price
  10.3.1 Global Nootropic Sales Growth (2013-2018)
  10.3.2 Global Nootropic Price (2013-2018)

11 GLOBAL PERFORMANCE ENHANCING DRUGS MARKET SEGMENT BY APPLICATION

11.1 Global Performance Enhancing Drugs Sales Market Share by Application (2013-2018)
11.2 Athletes Sales Growth (2013-2018)
11.3 Body Builders Sales Growth (2013-2018)
11.4 Students Sales Growth (2013-2018)
11.5 Militaries Sales Growth (2013-2018)

12 PERFORMANCE ENHANCING DRUGS MARKET FORECAST (2018-2023)

12.1 Global Performance Enhancing Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Performance Enhancing Drugs Market Forecast by Regions (2018-2023)
  12.2.1 North America Performance Enhancing Drugs Market Forecast (2018-2023)
  12.2.2 Europe Performance Enhancing Drugs Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Performance Enhancing Drugs Market Forecast (2018-2023)
  12.2.4 South America Performance Enhancing Drugs Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Performance Enhancing Drugs Market Forecast (2018-2023)
12.3 Performance Enhancing Drugs Market Forecast by Type (2018-2023)
  12.3.1 Global Performance Enhancing Drugs Sales Forecast by Type (2018-2023)
  12.3.2 Global Performance Enhancing Drugs Market Share Forecast by Type (2018-2023)
12.4 Performance Enhancing Drugs Market Forecast by Application (2018-2023)
  12.4.1 Global Performance Enhancing Drugs Sales Forecast by Application (2018-2023)
  12.4.2 Global Performance Enhancing Drugs Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Performance Enhancing Drugs Picture
Table Product Specifications of Performance Enhancing Drugs
Figure Global Sales Market Share of Performance Enhancing Drugs by Types in 2017
Table Performance Enhancing Drugs Types for Major Manufacturers
Figure Ergogenic Aids Picture
Figure Nootropic Picture
Figure Performance Enhancing Drugs Sales Market Share by Applications in 2017
Figure Athletes Picture
Figure Body Builders Picture
Figure Students Picture
Figure Militaries Picture
Figure United States Performance Enhancing Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Performance Enhancing Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Performance Enhancing Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Performance Enhancing Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Performance Enhancing Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Performance Enhancing Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Performance Enhancing Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Performance Enhancing Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Performance Enhancing Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Performance Enhancing Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Performance Enhancing Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Performance Enhancing Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Performance Enhancing Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Performance Enhancing Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Performance Enhancing Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Performance Enhancing Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Performance Enhancing Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Performance Enhancing Drugs Revenue (Value) and Growth Rate (2013-2023)
Table Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Taj Pharmaceuticals Performance Enhancing Drugs Type and Applications
Table Taj Pharmaceuticals Performance Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Balkan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Balkan Pharmaceuticals Performance Enhancing Drugs Type and Applications
Table Balkan Pharmaceuticals Performance Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Performance Enhancing Drugs Type and Applications
Table Bayer Performance Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Performance Enhancing Drugs Type and Applications
Table AstraZeneca Performance Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Performance Enhancing Drugs Type and Applications
Table Novo Nordisk Performance Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BrainAlert Basic Information, Manufacturing Base and Competitors
Table BrainAlert Performance Enhancing Drugs Type and Applications
Table BrainAlert Performance Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Douglas Laboratories Basic Information, Manufacturing Base and Competitors
Table Douglas Laboratories Performance Enhancing Drugs Type and Applications
Table Douglas Laboratories Performance Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Onnit Labs Basic Information, Manufacturing Base and Competitors
Table Onnit Labs Performance Enhancing Drugs Type and Applications
Table Onnit Labs Performance Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly And Company Basic Information, Manufacturing Base and Competitors
Table Eli Lilly And Company Performance Enhancing Drugs Type and Applications
Table Eli Lilly And Company Performance Enhancing Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Performance Enhancing Drugs Sales by Manufacturer (2016-2017)
Figure Global Performance Enhancing Drugs Sales Market Share by Manufacturer in 2016
Figure Global Performance Enhancing Drugs Sales Market Share by Manufacturer in 2017
Table Global Performance Enhancing Drugs Revenue by Manufacturer (2016-2017)
Figure Global Performance Enhancing Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Performance Enhancing Drugs Revenue Market Share by Manufacturer in 2017
Figure Top 3 Performance Enhancing Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Performance Enhancing Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure Global Performance Enhancing Drugs Revenue and Growth Rate (2013-2018)
Table Global Performance Enhancing Drugs Sales by Regions (2013-2018)
Table Global Performance Enhancing Drugs Sales Market Share by Regions (2013-2018)
Table Global Performance Enhancing Drugs Revenue by Regions (2013-2018)
Figure Global Performance Enhancing Drugs Revenue Market Share by Regions in 2013
Figure Global Performance Enhancing Drugs Revenue Market Share by Regions in 2017
Figure North America Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure Europe Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure South America Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure North America Performance Enhancing Drugs Revenue and Growth Rate (2013-2018)
Table North America Performance Enhancing Drugs Sales by Countries (2013-2018)
Table North America Performance Enhancing Drugs Sales Market Share by Countries (2013-2018)
Figure North America Performance Enhancing Drugs Sales Market Share by Countries in 2013
Figure North America Performance Enhancing Drugs Sales Market Share by Countries in 2017
Table North America Performance Enhancing Drugs Revenue by Countries (2013-2018)
Table North America Performance Enhancing Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Performance Enhancing Drugs Revenue Market Share by Countries in 2013
Figure North America Performance Enhancing Drugs Revenue Market Share by Countries in 2017
Figure United States Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure Canada Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure Europe Performance Enhancing Drugs Revenue and Growth Rate (2013-2018)
Table Europe Performance Enhancing Drugs Sales by Countries (2013-2018)
Table Europe Performance Enhancing Drugs Sales Market Share by Countries (2013-2018)
Table Europe Performance Enhancing Drugs Revenue by Countries (2013-2018)
Figure Europe Performance Enhancing Drugs Revenue Market Share by Countries in 2016
Figure Europe Performance Enhancing Drugs Revenue Market Share by Countries in 2017
Figure Germany Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure UK Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure France Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure Russia Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure Italy Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Performance Enhancing Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Performance Enhancing Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Performance Enhancing Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Performance Enhancing Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Performance Enhancing Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Performance Enhancing Drugs Revenue Market Share by Countries 2017
Figure China Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure Japan Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure Korea Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure India Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure South America Performance Enhancing Drugs Revenue and Growth Rate (2013-2018)
Table South America Performance Enhancing Drugs Sales by Countries (2013-2018)
Table South America Performance Enhancing Drugs Sales Market Share by Countries (2013-2018)
Figure South America Performance Enhancing Drugs Sales Market Share by Countries in 2017
Table South America Performance Enhancing Drugs Revenue by Countries (2013-2018)
Table South America Performance Enhancing Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Performance Enhancing Drugs Revenue Market Share by Countries in 2017
Figure Brazil Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Performance Enhancing Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Performance Enhancing Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Performance Enhancing Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Performance Enhancing Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Performance Enhancing Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Performance Enhancing Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Performance Enhancing Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Performance Enhancing Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure UAE Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Performance Enhancing Drugs Sales and Growth Rate (2013-2018)
Table Global Performance Enhancing Drugs Sales by Type (2013-2018)
Table Global Performance Enhancing Drugs Sales Share by Type (2013-2018)
Table Global Performance Enhancing Drugs Revenue by Type (2013-2018)
Table Global Performance Enhancing Drugs Revenue Share by Type (2013-2018)
Figure Global Ergogenic Aids Sales Growth (2013-2018)
Figure Global Ergogenic Aids Price (2013-2018)
Figure Global Nootropic Sales Growth (2013-2018)
Figure Global Nootropic Price (2013-2018)
Table Global Performance Enhancing Drugs Sales by Application (2013-2018)
Table Global Performance Enhancing Drugs Sales Share by Application (2013-2018)
Figure Global Body Builders Sales Growth (2013-2018)
Figure Global Students Sales Growth (2013-2018)
Figure Global Militaries Sales Growth (2013-2018)
Figure Global Performance Enhancing Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Performance Enhancing Drugs Sales Forecast by Regions (2018-2023)
Table Global Performance Enhancing Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Performance Enhancing Drugs Market Forecast (2018-2023)
Figure Europe Sales Performance Enhancing Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Performance Enhancing Drugs Market Forecast (2018-2023)
Figure South America Sales Performance Enhancing Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Performance Enhancing Drugs Market Forecast (2018-2023)
Table Global Performance Enhancing Drugs Sales Forecast by Type (2018-2023)
Table Global Performance Enhancing Drugs Market Share Forecast by Type (2018-2023)
Table Global Performance Enhancing Drugs Sales Forecast by Application (2018-2023)
Table Global Performance Enhancing Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List